Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announces that it has successfully completed an underwritten public offering of 18,000,000 shares of its common stock to the public at a price of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback